← Expert Review of Precision Medicine and Drug Development
Papers in Expert Review of Precision Medicine and Drug Development
Page 3 · newest first
- Recent advances towards gene therapy for propionic acidemia: translation to the clinicExpert Review of Precision Medicine and Drug Development · 2019
- Impact of NCI-MATCH: a Nationwide Oncology Precision Medicine TrialExpert Review of Precision Medicine and Drug Development · 2019
- Precision medicine for the treatment of sepsis: recent advances and future prospectsExpert Review of Precision Medicine and Drug Development · 2019
- New treatment targets in multiple sclerosis therapyExpert Review of Precision Medicine and Drug Development · 2019
- Use of big data in drug development for precision medicine: an updateExpert Review of Precision Medicine and Drug Development · 2019
- Gilteritinib for the treatment of patients withFLT3mutated relapsed or refractory acute myeloid leukemiaExpert Review of Precision Medicine and Drug Development · 2019
- Advances in precision epigenetic treatment for acute promyelocytic leukemia.Expert Review of Precision Medicine and Drug Development · 2019
- Novel therapeutic targets and drug development for the precision treatment of COPDExpert Review of Precision Medicine and Drug Development · 2019
- Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeuticsExpert Review of Precision Medicine and Drug Development · 2019
- An analysis of available biomarker data for targeting cyclin-dependent kinases 4 and 6 (CDK4/6) in breast cancerExpert Review of Precision Medicine and Drug Development · 2019
- Deep learning and radiomics in precision medicineExpert Review of Precision Medicine and Drug Development · 2019
- Privacy and ethical challenges in next-generation sequencingExpert Review of Precision Medicine and Drug Development · 2019
- Precision therapy in advanced urothelial cancerExpert Review of Precision Medicine and Drug Development · 2019
- Development pathways for subcutaneous formulations of biologics versus biosimilar developmentExpert Review of Precision Medicine and Drug Development · 2019
- Recent advances in precision medicine for the treatment of anaplastic thyroid cancerExpert Review of Precision Medicine and Drug Development · 2019
- Development and implementation of precision therapies targeting base-excision DNA repair in BRCA1-associated tumorsExpert Review of Precision Medicine and Drug Development · 2019
- Emerging DNA methylation inhibitors for cancer therapy: challenges and prospectsExpert Review of Precision Medicine and Drug Development · 2019
- The potential of genotype-guided antiplatelet therapy: promises and challengesExpert Review of Precision Medicine and Drug Development · 2018
- The potential of precision medicine for childhood acute lymphoblastic leukemia: opportunities and challengesExpert Review of Precision Medicine and Drug Development · 2018
- Modulating the cystic fibrosis transmembrane regulator and the development of new precision drugsExpert Review of Precision Medicine and Drug Development · 2018
- Leaving some behind: the growing gap in precision medicine for minority populationsExpert Review of Precision Medicine and Drug Development · 2018
- Big data, artificial intelligence, and cardiovascular precision medicineExpert Review of Precision Medicine and Drug Development · 2018
- Ex ante economic evaluation of genetic testing for the ARG389 beta1-adrenergic receptor polymorphism to support bucindolol treatment decisions in Stage III/IV heart failureExpert Review of Precision Medicine and Drug Development · 2018
- Lessons in practicing cancer genomics and precision medicineExpert Review of Precision Medicine and Drug Development · 2018
- Personalizing the approach to asthma treatmentExpert Review of Precision Medicine and Drug Development · 2018
- The value of genetic risk scores in precision medicine for diabetesExpert Review of Precision Medicine and Drug Development · 2018
- Precision medicine for age-related macular degeneration: current developments and prospectsExpert Review of Precision Medicine and Drug Development · 2018
- Personalized treatment in the epilepsies: challenges and opportunitiesExpert Review of Precision Medicine and Drug Development · 2018
- Population-level pharmacogenomics for precision drug development in dementiaExpert Review of Precision Medicine and Drug Development · 2018
- Overcoming diagnostic issues in precision treatment of pancreatic cancerExpert Review of Precision Medicine and Drug Development · 2018
- TRAIL pathway targeting therapeuticsExpert Review of Precision Medicine and Drug Development · 2018
- The interaction between vitamin C and bone health: a narrative reviewExpert Review of Precision Medicine and Drug Development · 2018
- Immunotherapy and next-generation sequencing guided therapy for precision oncology: what have we learnt and what does the future hold?Expert Review of Precision Medicine and Drug Development · 2018
- Tailored approaches to rare sarcomas: current challenges and future prospectsExpert Review of Precision Medicine and Drug Development · 2018
- ‘You-on-a-chip’ for precision medicineExpert Review of Precision Medicine and Drug Development · 2018
- Progress towards precision medicine for lupus: the role of genetic biomarkersExpert Review of Precision Medicine and Drug Development · 2018
- Cystic fibrosis: a model for precision medicineExpert Review of Precision Medicine and Drug Development · 2018
- PARP inhibitors and breast cancer: highlights and hang-upsExpert Review of Precision Medicine and Drug Development · 2018
- Microbes in food to treat and prevent diseaseExpert Review of Precision Medicine and Drug Development · 2018
- The economic case for precision medicineExpert Review of Precision Medicine and Drug Development · 2018
- Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatmentExpert Review of Precision Medicine and Drug Development · 2018
- The role for rapid molecular diagnostic tests for infectious diseases in precision medicineExpert Review of Precision Medicine and Drug Development · 2018
- Drug repositioning: current approaches and their implications in the precision medicine eraExpert Review of Precision Medicine and Drug Development · 2018
- RET rearrangements in non–small cell lung cancer and implications for the future of precision drug developmentExpert Review of Precision Medicine and Drug Development · 2018
- Circulating tumor DNA: an important tool in precision medicine for lymphomaExpert Review of Precision Medicine and Drug Development · 2017
- Midostaurin and emerging FLT3 inhibitors for the treatment of adults with newly diagnosed acute myeloid leukemia with the FLT3 mutationExpert Review of Precision Medicine and Drug Development · 2017
- Integrating pharmacogenetic testing into primary careExpert Review of Precision Medicine and Drug Development · 2017
- Personalized peptide vaccines for cancer therapy: current progress and state of the artExpert Review of Precision Medicine and Drug Development · 2017
- Precision medicine for multiple sclerosis: an update of the available biomarkers and their use in therapeutic decision makingExpert Review of Precision Medicine and Drug Development · 2017
- Biosensors and personalized drug therapy: what does the future hold?Expert Review of Precision Medicine and Drug Development · 2017